1995Unpublished venueRequires access

Amlodipine vs nitrendipine in treating aged patients with hypertensive disease

Ren We

Open publisher page 0 citations

Abstract

AIM: To compare between amlodipine and nitrendipine in treating aged patients with hypertensive disease. METHODS: In a randomized single-blind and parallel study ,41 patients (M29,F 12: age62.7±s 1.0a)received amlodipine 5-10 mg,po,qm,for 4 wk; 21 patients (M14,F 7: age62.2±s 1.3 a)received nitrendipine 10-20 mg,po,q 12h for 4 wk. RESULTS: The clinical total effective rate of amlodipine group was 93%, similar to the nitrendipine group 86%(P0.05); there were the remarkable reduction in blood glucose and triglycerides in amlodipine group. Adverse effects of amlodipine group were fewer than those of nitrendipine group(15% vs 21%, P0.01). CONCLUSION: Amlodipine is superior to nitrendipine in treating hypertensive disease in aged patients.

About this research paper

What this paper is about

AIM: To compare between amlodipine and nitrendipine in treating aged patients with hypertensive disease. METHODS: In a randomized single-blind and parallel study ,41 patients (M29,F 12: age62.7±s 1.0a)received amlodipine 5-10 mg,po,qm,for 4 wk; 21 patients (M14,F 7: age62.2±s 1.3 a)received nitrendipine 10-20 mg,po,q 12h for 4 wk. RESULTS: The clinical total effective rate of amlodipine group was 93%, similar to the nitrendipine group 86%(P0.05); there were the remarkable reduction in blood glucose and triglycerides in amlodipine group. Adverse effects of amlodipine group were fewer than those of nitrendipine group(15% vs 21%, P0.01). CONCLUSION: Amlodipine is superior to nitrendipine in treating hypertensive disease in aged patients.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

AIM: To compare between amlodipine and nitrendipine in treating aged patients with hypertensive disease. METHODS: In a randomized single-blind and parallel study ,41 patients (M29,F 12: age62.7±s 1.0a)received amlodipine 5-10 mg,po,qm,for 4 wk; 21 patients (M14,F 7: age62.2±s 1.3 a)received nitrendipine 10-20 mg,po,q 12h for 4 wk. RESULTS: The clinical total effective rate of amlodipine group was 93%, similar to the nitrendipine group 86%(P0.05); there were the remarkable reduction in blood glucose and triglycerides in amlodipine group. Adverse effects of amlodipine group were fewer than those of nitrendipine group(15% vs 21%, P0.01). CONCLUSION: Amlodipine is superior to nitrendipine in treating hypertensive disease in aged patients.

Key concepts: Nitrendipine, Amlodipine, Medicine, Hypertensive disease, Internal medicine, Blood pressure

Related papers

Back to paper searchBrowse research topicsOriginal source
Amlodipine vs nitrendipine in treating aged patients with hypertensive disease — Research Paper | ScholarLens